Adel B Alharbi

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Transcription Factor

Diabetic Nephropathy

Metabolic Syndrome

Top Venues

International journal of molecular sciences

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid, Anmar A Khan, Riyad Adnan Almaimani, Shakir Idris, Mohamed Elzubier Elzubier, Elshiekh Babiker A Khidir, Akhmed Aslam, Faisal Minshawi, Mohammad A Alobaidy, Adel B Alharbi, Hussain A Almasmoum, Mazen Ghaith, Khalid M Alquthami, Bassem Refaat
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International journal of molecular sciences 24 (24) (2023)
Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid, Anmar A Khan, Riyad Adnan Almaimani, Shakir Idris, Mohamed Elzubier Elzubier, Elshiekh Babiker A Khidir, Akhmed Aslam, Faisal Minshawi, Mohammad A Alobaidy, Adel B Alharbi, Hussain A Almasmoum, Mazen Ghaith, Khalid M Alquthami, Bassem Refaat
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International journal of molecular sciences 24 (24) (2023)
Adel B Alharbi, Ulf Schmitz, Charles G Bailey, John E J Rasko
CTCF as a regulator of alternative splicing: new tricks for an old player. Nucleic acids research 49 (14) (2021)
Adel B Alharbi, Ulf Schmitz, Amy D Marshall, Darya P Vanichkina, Rajini Nagarajah, Melissa Vellozzi, Justin Jong-Leong Wong, Charles G Bailey, John Ej Rasko
Ctcf haploinsufficiency mediates intron retention in a tissue-specific manner. RNA biology 18 (1) (2020)